Physiological cardiac remodelling in response to endurance exercise training: Cellular and molecular mechanisms

Heart

Volumn 98, Issue 1, 2012, Pages 5-10

  Ellison, Georgina M ^a,b   Waring, Cheryl D ^a   Vicinanza, Carla ^b   Torella, Daniele ^a,b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CCAAT ENHANCER BINDING PROTEIN; CD45 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; HEAT SHOCK PROTEIN 70; HISTONE ACETYLTRANSFERASE PCAF; MESSENGER RNA; MICRORNA; NEU DIFFERENTIATION FACTOR; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SCATTER FACTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; TROPONIN; VASCULOTROPIN;

AEROBIC EXERCISE; ANGIOGENESIS; APOPTOSIS; BASE PAIRING; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL GROWTH; CELL LINEAGE; CELL REGENERATION; CELL RENEWAL; CHANNEL GATING; CYTOLOGY; ENDURANCE TRAINING; HEART CONTRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE RELAXATION; HEART VENTRICLE HYPERTROPHY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR; RISK REDUCTION; RNA DEGRADATION; SIGNAL TRANSDUCTION; STEM CELL; TISSUE SPECIFICITY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOMEGALY, EXERCISE-INDUCED; EXERCISE; GENE EXPRESSION; HEART; HUMANS; MICE; MICRORNAS; MYOBLASTS, CARDIAC; MYOCYTES, CARDIAC; RABBITS; REGENERATION; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84155160706     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300639     Document Type: Review

References (102)

1. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation 1999;99:963-72. (Pubitemid 29094312)
2. George K, Spence A, Naylor L, et al. Cardiac Adaptation to Acute and Chronic Participation in Endurance Sports. Heart 2011;97:1999-2004.
3. Blair SN, Kampert JB, Kohl HW 3rd, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996;276:205-10. (Pubitemid 26235064)
4. Weeks KL, McMullen JR. The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology 2011;26:97-105.
5. Opie LH, Commerford PJ, Gersh BJ, et al. Controversies in ventricular remodelling. Lancet 2006;367:356-67. (Pubitemid 43151469)
6. Kemi OJ, Loennechen JP, Wisløff U, et al. Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy. J Appl Physiol 2002;93:1301-9.
7. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301.
8. Shave R, Baggish A, George K, et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol 2010;56:169-76.
9. Benito B, Gay-Jordi G, Serrano-Mollar A, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011;123:13-22.
10. Volders PG. Marathon rat: myocardial remodeling in an animal model of vigorous endurance exercise and implications for humans. Circulation 2011;123:5-7.
11. Jin H, Yang R, Li W, et al. Effects of exercise training on cardiac function, gene expression, and apoptosis in rats. Am J Physiol Heart Circ Physiol 2000;279: H2994-3002. (Pubitemid 32005891)
12. Kwak HB, Song W, Lawler JM. Exercise training attenuates age-induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the rat heart. FASEB J 2006;20:791-3. (Pubitemid 46671217)
13. Siu PM, Bryner RW, Martyn JK, et al. Apoptotic adaptations from exercise training in skeletal and cardiac muscles. FASEB J 2004;18:1150-2. (Pubitemid 39561553)
14. Garrido C, Gurbuxani S, Ravagnan L, et al. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001;286:433-42. (Pubitemid 32912965)
15. Suzuki K, Sawa Y, Kagisaki K, et al. Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70. Basic Res Cardiol 2000;95:397-403.
16. Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science 2011;331:1078-80.
17. Jonas RA, Giglia TM, Sanders SP, et al. Rapid, two-stage arterial switch for transposition of the great arteries and intact ventricular septum beyond the neonatal period. Circulation 1989;80:1203-8.
18. Nadal Ginard B, Mahdavi V. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches. J Clin Invest 1989;84:1693-700. (Pubitemid 20016170)
19. Zheng J, Ding W, Xiao Y, et al. Anomalous origin of the left coronary artery from the pulmonary artery in children: 15 years experience. Pediatr Cardiol 2011;32:24-31.
20. Torella D, Ellison GM, Karakikes I, et al. Resident cardiac stem cells. Cell Mol Life Sci 2007;64:661-73.
21. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76. (Pubitemid 37186770)
22. Ellison GM, Torella D, Karakikes I, et al. Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. Nat Clin Pract Cardiovasc Med 2007;4 (Suppl 1):S52-9. (Pubitemid 46151905)
23. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A 2003;100:10440-5. (Pubitemid 37071897)
24. Nadal-Ginard B, Kajstura J, Leri A, et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003;92:139-50. (Pubitemid 36254270)
25. Overy HR, Priest RE. Mitotic cell division in postnatal cardiac growth. Lab Invest 1966;15:1100-3.
26. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1-14. (Pubitemid 28322094)
27. Hsieh PC, Segers VF, Davis ME, et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007;13:970-4. (Pubitemid 47222045)
28. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7. (Pubitemid 32497029)
29. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
30. Boström P, Mann N, Wu J, et al. C/EBPb controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010;143:1072-83.
31. Tam SK, Gu W, Mahdavi V, et al. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann NY Acad Sci 1995;752:72-9.
32. Wu SM, Fujiwara Y, Cibulsky SM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006;127:1137-50. (Pubitemid 44914005)
33. Waring CD, Papalambrou A, Sharp L, et al. Cardiac stem cell activation and ensuing myogenesis and angiogenesis contribute to cardiac adaptation following intensity-controlled exercise training. Circulation 2010;122:A19155.
34. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.
35. Laughlin MH. Effects of exercise training on coronary transport capacity. J Appl Physiol 1985;58:468-76. (Pubitemid 15057758)
36. Laughlin MH, Overholser KA, Bhatte MJ. Exercise training increases coronary transport reserve in miniature swine. J Appl Physiol 1989;67:1140-9. (Pubitemid 19245040)
37. White FC, Bloor CM, McKirnan MD, et al. Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol 1998;85:1160-8. (Pubitemid 28413299)
38. Black MA, Cable NT, Thijssen DH, et al. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol 2009;297: H1109-16.
39. Brown MD. Exercise and coronary vascular remodelling in the healthy heart. Exp Physiol 2003;88:645-58. (Pubitemid 37121739)
40. Thijssen DH, Torella D, Hopman MT, et al. The role of endothelial progenitor and cardiac stem cells in the cardiovascular adaptations to age and exercise. Front Biosci 2009;14:4685-702.
41. Kemi OJ, Wisløff U. Mechanisms of exercise-induced improvements in the contractile apparatus of the mammalian myocardium. Acta Physiol 2010;199:425-39.
42. Dorn GW 2nd. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 2007;49:962-70.
43. Bernardo BC, Weeks KL, Pretorius L, et al. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 2010;128:191-227.
44. Izumo S, Lompré AM, Matsuoka R, et al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 1987;79:970-7. (Pubitemid 17050926)
45. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A 1988;85:339-43.
46. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 2000;62:289-319. (Pubitemid 30618265)
47. McMullen JR, Shioi T, Zhang L, et al. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 2003;100:12355-60. (Pubitemid 37271564)
48. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 1997;59:551-71. (Pubitemid 27142455)
49. Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 2003;92:1079-88. (Pubitemid 36665853)
50. Bisping E, Ikeda S, Kong SW, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci U S A 2006;103:14471-6. (Pubitemid 44484774)
51. McMullen JR. Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease. Clin Exp Pharmacol Physiol 2008;35:349-54. (Pubitemid 351257887)
52. Neri Serneri GG, Boddi M, Modesti PA, et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 2001;89:977-82. (Pubitemid 34640863)
53. Reiss K, Cheng W, Ferber A, et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A 1996;93:8630-5. (Pubitemid 26269611)
54. Delaughter MC, Taffet GE, Fiorotto ML, et al. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J 1999;13:1923-9. (Pubitemid 29517622)
55. McMullen JR, Shioi T, Huang WY, et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110alpha) pathway. J Biol Chem 2004;279:4782-93. (Pubitemid 38199073)
56. Luo J, McMullen JR, Sobkiw CL, et al. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 2005;25:9491-502. (Pubitemid 41507849)
57. Kim J, Wende AR, Sena S, et al. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol 2008;22:2531-43.
58. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004;94:514-24. (Pubitemid 38326287)
59. Santini MP, Tsao L, Monassier L, et al. Enhancing repair of the mammalian heart. Circ Res 2007;100:1732-40. (Pubitemid 46987865)
60. Shioi T, Kang PM, Douglas PS, et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 2000;19:2537-48. (Pubitemid 30323543)
61. McMullen JR, Amirahmadi F, Woodcock EA, et al. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 2007;104:612-17. (Pubitemid 46123073)
62. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005;38:63-71. (Pubitemid 40038652)
63. Condorelli G, Drusco A, Stassi G, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 2002;99:12333-8.
64. Matsui T, Li L, Wu JC, et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 2002;277:22896-901. (Pubitemid 34967272)
65. Shioi T, McMullen JR, Kang PM, et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 2002;22:2799-809. (Pubitemid 34263000)
66. Shiojima I, Sato K, Izumiya Y, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-18. (Pubitemid 41134152)
67. DeBosch B, Treskov I, Lupu TS, et al. Akt1 is required for physiological cardiac growth. Circulation 2006;113:2097-104.
68. Shiraishi I, Melendez J, Ahn Y, et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 2004;94:884-91. (Pubitemid 38490065)
69. Fischer KM, Din S, Gude N, et al. Cardiac progenitor cell commitment is inhibited by nuclear Akt expression. Circ Res 2011;108:960-70.
70. Seddon M, Shah AM, Casadei B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 2007;75:315-26. (Pubitemid 46961933)
71. Indolfi C, Torella D, Coppola C, et al. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res 2002;91:1190-7. (Pubitemid 36076369)
72. Balligand JL, Feron O, Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 2009;89:481-534.
73. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-5.
74. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008;28:208-16. (Pubitemid 351161191)
75. Kemi OJ, Ellingsen O, Ceci M, et al. Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban. J Mol Cell Cardiol 2007;43:354-61. (Pubitemid 47307347)
76. Kemi OJ, Ellingsen O, Smith GL, et al. Exercise-induced changes in calcium handling in left ventricular cardiomyocytes. Front Biosci 2008;13:356-68. (Pubitemid 351606129)
77. Catalucci D, Zhang DH, DeSantiago J, et al. Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol 2009;184:923-33.
78. Catalucci D, Latronico MV, Ceci M, et al. Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17. J Biol Chem 2009;284:28180-7.
79. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5. (Pubitemid 39265675)
80. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
81. Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res 2007;101:1225-36. (Pubitemid 350294639)
82. Cordes KR, Srivastava D. MicroRNA regulation of cardiovascular development. Circ Res 2009;104:724-32.
83. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010;18:510-25.
84. Wang S, Olson EN. AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 2009;19:205-11.
85. Parmacek MS. MicroRNA-modulated targeting of vascular smooth muscle cells. J Clin Invest 2009;119:2526-8.
86. Catalucci D, Latronico MV, Condorelli G. MicroRNAs control gene expression: importance for cardiac development and pathophysiology. Ann NY Acad Sci 2008;1123:20-9. (Pubitemid 351431300)
87. Carè A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613-18. (Pubitemid 46828487)
88. Lin RC, Weeks KL, Gao XM, et al. PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 2010;30:724-32.
89. Soci UP, Fernandes T, Hashimoto NY, et al. MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics 2011;43:665-73.
90. van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008;105:13027-32.
91. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-16. (Pubitemid 36758987)
92. Yasuda S, Goto Y, Takaki H, et al. Exercise-induced hepatocyte growth factor production in patients after acute myocardial infarction: its relationship to exercise capacity and brain natriuretic peptide levels. Circulation 2004;68:304-7. (Pubitemid 38470702)
93. Laufs U, Werner N, Link A, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109:220-6. (Pubitemid 38114143)
94. Gustafsson T, Rundqvist H, Norrbom J, et al. The influence of physical training on the angiopoietin and VEGF-A systems in human skeletal muscle. J Appl Physiol 2007;103:1012-20. (Pubitemid 47358888)
95. Rastaldo R, Pagliaro P, Cappello S, et al. Nitric oxide and cardiac function. Life Sci 2007;81:779-93. (Pubitemid 47332516)
96. Czarkowska-Paczek B, Bartlomiejczyk I, Przybylski J. The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise. J Physiol Pharmacol 2006;57:189-97. (Pubitemid 44077745)
97. Torella D, Ellison GM, Karakikes I, et al. Growth-factor-mediated cardiac stem cell activation in myocardial regeneration. Nat Clin Pract Cardiovasc Med 2007;4 (Suppl 1):S46-51. (Pubitemid 46164270)
98. Kuhn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007;13:962-9. (Pubitemid 47222046)
99. Bersell K, Arab S, Haring B, et al. Neuregulin1/erbb4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009;138:257-70.
100. Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by IGF-1/HGF intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011;58:977-86.
101. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-42.
102. Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-9.